Stockreport

NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy

NewcelX Ltd. - Ordinary Shares  (NCEL) 
PDF Publication strengthens scientific positioning as Company progresses strategic discussions related to CVR-linked assetZURICH, Feb. 12, 2026 /PRNewswire/ -- NewcelX Ltd. [Read more]